DK0697891T3 - Polyoximforbindelser og fremstilling deraf - Google Patents
Polyoximforbindelser og fremstilling derafInfo
- Publication number
- DK0697891T3 DK0697891T3 DK94913192T DK94913192T DK0697891T3 DK 0697891 T3 DK0697891 T3 DK 0697891T3 DK 94913192 T DK94913192 T DK 94913192T DK 94913192 T DK94913192 T DK 94913192T DK 0697891 T3 DK0697891 T3 DK 0697891T3
- Authority
- DK
- Denmark
- Prior art keywords
- baseplate
- polyoxime
- preparation
- organic molecules
- organic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5759493A | 1993-05-05 | 1993-05-05 | |
US08/114,877 US6174530B1 (en) | 1993-05-05 | 1993-08-31 | Homogeneous polyoxime compositions and their preparation by parallel assembly |
US08/105,904 US6001364A (en) | 1993-05-05 | 1993-08-31 | Hetero-polyoxime compounds and their preparation by parallel assembly |
PCT/IB1994/000093 WO1994025071A1 (en) | 1993-05-05 | 1994-05-05 | Polyoxime compounds and their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0697891T3 true DK0697891T3 (da) | 2000-09-04 |
Family
ID=27369284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94913192T DK0697891T3 (da) | 1993-05-05 | 1994-05-05 | Polyoximforbindelser og fremstilling deraf |
Country Status (11)
Country | Link |
---|---|
US (1) | US6663869B1 (el) |
EP (1) | EP0697891B1 (el) |
JP (1) | JP3734828B2 (el) |
AT (1) | ATE191148T1 (el) |
AU (1) | AU686153B2 (el) |
CA (1) | CA2162157A1 (el) |
DE (1) | DE69423753T2 (el) |
DK (1) | DK0697891T3 (el) |
ES (1) | ES2146649T3 (el) |
GR (1) | GR3033699T3 (el) |
PT (1) | PT697891E (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004099246A2 (en) * | 2003-05-09 | 2004-11-18 | Novo Nordisk A/S | Peptides for use in treating obesity |
KR20060026011A (ko) * | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | 비만 치료용 펩티드 |
KR20080031414A (ko) * | 2005-07-18 | 2008-04-08 | 노보 노르디스크 에이/에스 | 비만치료에 사용하기 위한 신규 펩티드 |
WO2008013735A2 (en) * | 2006-07-21 | 2008-01-31 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
US20100022446A1 (en) * | 2007-01-18 | 2010-01-28 | Novo Nordisk A/S | Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity |
JP2010516652A (ja) * | 2007-01-18 | 2010-05-20 | ノボ・ノルデイスク・エー/エス | 肥満の治療に使用される新規ペプチド |
EP2104684A1 (en) * | 2007-01-18 | 2009-09-30 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
CA2712606A1 (en) | 2008-02-08 | 2009-08-13 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
JP2012509862A (ja) * | 2008-11-25 | 2012-04-26 | ノヴォ・ノルディスク・アー/エス | 肥満の治療のためのペプチド |
US8647621B2 (en) | 2009-07-27 | 2014-02-11 | Fina Biosolutions, Llc | Method of producing protein-carbohydrate vaccines reduced in free carbohydrate |
JP6564539B1 (ja) | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | スルホン酸化合物によるペプチド精製方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444744A (en) | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
US4622420A (en) | 1980-03-18 | 1986-11-11 | The Regents Of The University Of California | Chelating agents and method |
US4865835A (en) | 1982-06-02 | 1989-09-12 | Begent Richard H J | Diagnosis and treatment of tumors |
US4507466A (en) | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
JPS59215321A (ja) | 1983-05-23 | 1984-12-05 | Sumitomo Chem Co Ltd | 二官能性配位子化合物を結合した反応性高分子 |
US4707352A (en) | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
US4652440A (en) | 1984-05-03 | 1987-03-24 | Paik Chang H | Method of stably radiolabeling antibodies with technetium and rhenium |
IL71947A (en) | 1984-05-29 | 1987-10-30 | Yeda Research And Dev Comp Ltd | Enzyme hydrazides and method for detection and determination of glycoconjugates |
US4659839A (en) | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
US4678667A (en) | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
GB8610551D0 (en) | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
IN165717B (el) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
JPH0611290B2 (ja) | 1986-11-05 | 1994-02-16 | 住友ベークライト株式会社 | ポリビニルアルコ−ルゲルのγ線滅菌法 |
US4861581A (en) | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
US5084266A (en) | 1988-02-03 | 1992-01-28 | The University Of Melbourne | Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody |
US4857599A (en) | 1988-02-08 | 1989-08-15 | The Dow Chemical Company | Modified dense star polymers |
GB8820377D0 (en) | 1988-08-26 | 1988-09-28 | Offord R E | Chemical compounds |
GB9004538D0 (en) * | 1990-02-28 | 1990-04-25 | Offord Robin E | Chemical compounds |
US5011676A (en) | 1990-03-27 | 1991-04-30 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
EP0510132B1 (en) * | 1990-09-28 | 1997-05-14 | Neorx Corporation | Polymeric carriers for release of covalently linked agents |
GB9102450D0 (en) | 1991-02-05 | 1991-03-20 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
US6174530B1 (en) * | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
WO1994025071A1 (en) | 1993-05-05 | 1994-11-10 | Keith Rose | Polyoxime compounds and their preparation |
US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
-
1994
- 1994-05-05 AT AT94913192T patent/ATE191148T1/de not_active IP Right Cessation
- 1994-05-05 EP EP94913192A patent/EP0697891B1/en not_active Expired - Lifetime
- 1994-05-05 CA CA002162157A patent/CA2162157A1/en not_active Abandoned
- 1994-05-05 DK DK94913192T patent/DK0697891T3/da active
- 1994-05-05 PT PT94913192T patent/PT697891E/pt unknown
- 1994-05-05 DE DE69423753T patent/DE69423753T2/de not_active Expired - Fee Related
- 1994-05-05 AU AU65438/94A patent/AU686153B2/en not_active Ceased
- 1994-05-05 JP JP52408094A patent/JP3734828B2/ja not_active Expired - Fee Related
- 1994-05-05 ES ES94913192T patent/ES2146649T3/es not_active Expired - Lifetime
-
2000
- 2000-06-15 GR GR20000401389T patent/GR3033699T3/el not_active IP Right Cessation
- 2000-08-04 US US09/633,269 patent/US6663869B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69423753T2 (de) | 2000-11-02 |
AU686153B2 (en) | 1998-02-05 |
DE69423753D1 (de) | 2000-05-04 |
JP3734828B2 (ja) | 2006-01-11 |
GR3033699T3 (en) | 2000-10-31 |
AU6543894A (en) | 1994-11-21 |
EP0697891B1 (en) | 2000-03-29 |
JPH08510210A (ja) | 1996-10-29 |
ATE191148T1 (de) | 2000-04-15 |
PT697891E (pt) | 2000-09-29 |
ES2146649T3 (es) | 2000-08-16 |
EP0697891A1 (en) | 1996-02-28 |
US6663869B1 (en) | 2003-12-16 |
CA2162157A1 (en) | 1994-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0697891T3 (da) | Polyoximforbindelser og fremstilling deraf | |
CA2165561A1 (en) | Peralkylated Oligopeptide Mixtures | |
ES2141610T3 (es) | Compuestos con atomos espiranicos y su uso como materiales electroluminiscentes. | |
BR8504463A (pt) | Resina quimicamente endurecivel,processo para sua preparacao,misturas de compostos e misturas endurecidas de compostos | |
DK392084D0 (da) | Haerdelige materialer | |
EP0448717A4 (en) | Cement admixture, production thereof, and cement composition | |
DE68910032D1 (de) | Organische dünne Schicht durch regulierbare Molekularepitaxie. | |
KR870010123A (ko) | 내충격성 폴리아미드 성형 재료 | |
BR9707317A (pt) | Processo para fazer uma composição de resina termofixa espessada | |
KR880007567A (ko) | 아시알로당 단백질 수용체-역할화합물단위 및 그에 화학적으로 결합된 킬레이트 형성 화합물 단위를 함유한 고분자 화합물 및 그의 용도 | |
EP0380139A3 (en) | Organic nonlinear optical material | |
EP0245893A3 (en) | Catalyst compositions | |
DE60315274D1 (de) | Herstellungsverfahren von copolyestercarbonaten | |
CA2032669A1 (en) | Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers | |
NZ288857A (en) | Improving stability of biological pesticides | |
WO1993015203A3 (en) | Polypeptides with fibronectin binding sites as modulators for matrix assembly | |
CA2163240A1 (en) | Linear substituted oligoalkyleneimine libraries | |
BR9810210A (pt) | Melhoramentos em ou referentes a composiçõespoliméricas | |
JPS5650929A (en) | Polysulfone having carbon-carbon double bond on its side chain and its manufacture | |
ES2103194B1 (es) | Colorantes reactivos de aluminio-ftalocianina. | |
ES458753A1 (es) | Procedimiento para la preparacion de agentes de revestimien-to liquidos. | |
BR9910099A (pt) | Método para melhorar a aparência em revestimentos compósitos de cor extrabrilho, e composições para o uso no mesmo | |
KR890011920A (ko) | 이미드결합을 지닌 수지의 제조방법 및 수지를 함유하는 난연제 | |
KR910004748A (ko) | 경화형 조성물 | |
JPS6420226A (en) | Production of modified epoxy resin |